Cell cycle perturbation in the hepatocytes of HCV core transgenic mice following common bile duct ligation is associated with enhanced p21 expression

Journal of Medical Virology

Volumn 81, Issue 3, 2009, Pages 467-472

  Chang, Ming Ling ^a,b   Chen, Tsung Hsing ^a   Chang, Ming Yu ^a   Yeh, Chau Ting ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cell cycle; Common bile duct ligation; G1 arrest; HCV core protein; p21; Partial hepatectomy; Transgenic mice

Indexed keywords

CORE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLIN E1; HISTONE H3; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2; PROTEIN P21; TETRACYCLINE; UNCLASSIFIED DRUG; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; COMMON BILE DUCT; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VIRUS CORE; ANIMAL; BIOSYNTHESIS; CELL CYCLE; GENETICS; LIGATION; LIVER; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

HEPATITIS C VIRUS; MUS; MUS MUSCULUS;

ANIMALS; CELL CYCLE; COMMON BILE DUCT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HEPACIVIRUS; HEPATOCYTES; LIGATION; LIVER; MICE; MICE, TRANSGENIC; VIRAL CORE PROTEINS;

EID: 60049097892     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21403     Document Type: Article

References (28)

1. Blagosklonny MV. 2007. Mitotic arrest and cell fate: Why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 6:70-74.
2. Chang ML, Chen JC, Yeh CT, Sheen IS, Tai DI, Chang MY, Chiu CT, Lin DY, Bissell DM. 2007. Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: Studies in vitro and in conditionally transgenicmice. World J Gastroenterol 13:3472-3477.
3. Chang ML, Yeh CT, Chen JC, Huang CC, Lin SM, Sheen IS, Tai DI, Chu CM, Lin WP, Chang MY, Liang CK, Chiu CT, Lin DY. 2008a. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics 9:109.
4. Chang ML, Chen JC, Yeh CT, Lin DY, Chiu CT, Chang ML. 2008b. The various impacts of HCV core protein on hepatic oxidative stress after common bile duct ligation and partial hepatectomy. Redox Rep 13:172-178.
5. Chang ML, Chen JC, Chang MY, Yeh CT, Lin WP, Liang CK, Huang SF, Dang KN, Chiu CT, Lin DY. 2008c. Acute expression of hepatitis C core protein in adult mouse liver: Mitochondrial stress and apoptosis. Scand J Gastroenterol 43:747-755.
6. Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK, Eckhardt SG, Robinson WA. 2008. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112:822-829.
7. Dubourdeau M, Miyamura T, Matsuura Y, Alric L, Pipy B, Rousseau D. 2002. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation - Effect of transforming growth factor beta. J Hepatol 37:486-492.
8. Eigeliene N, Härkönen P, Erkkola R. 2008. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Cell Cycle 7:71-80.
9. Fattovich G, Stroffolini T, Zagni I, Donato F. 2004. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127:S35-S50.
10. Geerts AM, Cheung KJ, Van Vlierberghe H, De Vriese AS, Mortier S, Vanheule E, Lameire N, De Vos M, Colle I. 2007. Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatmentwith peginterferon: An in vivo study. J Hepatol 46:804-815.
11. Gourguechon S, Savich JM, Wang CC. 2007. The multiple roles of cyclin E1 in controlling cell cycle progression and cellular morphology of Trypanosoma brucei. J Mol Biol 368:939-950.
12. Hayashi J, Aoki H, Arakawa Y, Hino O. 1999. Hepatitis C virus and hepatocarcinogenesis. Intervirology 42:205-210.
13. Heathcote EJ. 2004. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 127:S294-S302.
14. Kasprzak A, Adamek A. 2008. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatol Res 38:1-26.
15. Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M. 2002. Molecular mechanism of viral hepatocarcinogenesis. Oncology 62:29-37.
16. Lo SY, Masiarz F, Hwang SB, Lai MM, Ou JH. 1995. Differential subcellular localization of hepatitis C virus core gene products. Virology 213:455-461.
17. Lu W, Lo SY, Chen M, Wu K, Fung YK, Ou JH. 1999. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264:134-141.
18. Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, Vowler SL, Coleman N, Alexander G. 2005. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 128:33-42.
19. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065-1067.
20. Nguyen H, Mudryj M, Guadalupe M, Dandekar S. 2003. Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle. Virology 312:245-253.
21. Ray RB, Meyer K, Ray R. 2000. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271:197-204.
22. Shao J, Qiao L, Janssen RC, Pagliassotti M, Friedman JE. 2005. Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes 54:976-984.
23. Siavoshian S, Abraham JD, Kieny MP, Schuster C. 2004. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Arch Virol 149:323-336.
24. Tang W, Lázaro CA, Campbell JS, Parks WT, Katze MG, Fausto N. 2007. Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame. Am J Pathol 171:1831-1846.
25. Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM. 2001. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 153:1023-1034.
26. Xu J, Deng X, Demetriou AA, Farkas DL, Hui T, Wang C. 2008. Factors released from cholestatic rat livers possibly involved in inducing bone marrow hepatic stem cell priming. Stem Cells Dev 17:143-155.
27. Yamanaka T, Uchida M, Doi T. 2002a. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem Biophys Res Commun 294:521-527.
28. Yamanaka T, Kodama T, Doi T. 2002b. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem Biophys Res Commun 294:528-534.